For decades, scientists have noticed a striking pattern in Parkinson’s disease: men develop the condition nearly twice as often as women. Historically, researchers attributed this gap to external factors, such as higher exposure to environmental toxins or a greater frequency of head injuries among men. However, a groundbreaking study presented at the 2026 Federation of European Neuroscience Societies Forum suggests that the real explanation lies deep within our brain cells.
Researchers examined post-mortem brain tissue across five different regions to uncover how biological sex impacts the disease at a cellular level. They discovered that while Parkinson’s causes universal stress responses in all brain cells, subtle genetic activity variations create distinct operational pathways between male and female brains.
Key Findings from the Research
- Shared Cellular Stress: Regardless of biological sex, Parkinson’s triggers widespread stress across neurons and support cells, forcing them to activate protective chaperone proteins.
- Energy Management Disparities: In astrocytes—the cells responsible for supporting brain metabolism—genes that regulate mitochondrial energy production show markedly different activity levels in men compared to women.
- Nerve Insulation Differences: In oligodendrocytes, which build protective myelin coatings around nerves, gene regulation differs significantly between the sexes.
- Epigenetic Variations: Women with Parkinson’s show widespread DNA methylation changes across dozens of genome regions, whereas men exhibit changes in far fewer areas.
Ultimately, these cellular clues explain why men face higher vulnerability and why the disease progresses differently across sexes. Consequently, these findings highlight a vital shift for the future of medicine: scientists must stop pooling male and female data together and instead design tailored, sex-specific treatments for neurodegenerative disorders.
For the full article click here.
